CV THERAPEUTICS INC
10-Q, EX-27.1, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: CV THERAPEUTICS INC, 10-Q, EX-10.80, 2000-08-14
Next: TRICO MARINE SERVICES INC, 10-Q, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains financial information extracted from the Consolidated
Balance Sheet as of June 30, 2000 and the Consolidated Statement of
Operations for the six month period ended June 30, 2000 and is qualified in
its entirety by reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                         225,259
<SECURITIES>                                    44,355
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               272,676
<PP&E>                                           9,023
<DEPRECIATION>                                 (6,386)
<TOTAL-ASSETS>                                 282,227
<CURRENT-LIABILITIES>                           10,370
<BONDS>                                        196,250
                                0
                                          0
<COMMON>                                       177,307
<OTHER-SE>                                   (107,983)
<TOTAL-LIABILITY-AND-EQUITY>                   282,227
<SALES>                                              0
<TOTAL-REVENUES>                                 2,000
<CGS>                                                0
<TOTAL-COSTS>                                   19,157
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               3,605
<INCOME-PRETAX>                               (14,466)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (14,466)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (14,466)
<EPS-BASIC>                                   (0.79)
<EPS-DILUTED>                                   (0.79)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission